Navigation Links
Anti-Inflammatory Helps Treat Bacterial Meningitis: Study
Date:9/29/2010

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Sept. 29 (HealthDay News) -- Using the anti-inflammatory drug dexamethasone along with antibiotics increases the chance of surviving a bout with bacterial meningitis, Dutch researchers report.

"Dexamethasone therapy reduces mortality from bacterial meningitis by one-third," said lead researcher Dr. Diederik van de Beek, a clinical neurologist from the Academic Medical Center at the University of Amsterdam.

"That's a huge effect," he added. "Normally, the death rate of bacterial meningitis is 30 percent; if you use dexamethasone, it decreases to 20 percent."

The report is published in the Sept. 29 online edition and the Oct. 26 print issue of Neurology.

For the study, van de Beek's team collected data on 357 people 16 and older who had bacterial meningitis between 2006 and 2009. Of these patients, 84 percent were given a dose of dexamethasone, a corticosteroid, before antibiotic treatment was started.

The researchers compared the outcomes of these patients with 352 patients treated for bacterial meningitis between 1998 and 2002, before dexamethasone was routinely given for the infection. Among these patients, only 3 percent had been given dexamethasone, the researchers noted.

Deaths among those given dexamethasone in the 2006-2009 study group were 10 percent lower than for those in the early study group. In addition, hearing loss was almost 10 percent lower for people in the 2006-2009 study group compared with the earlier group, the investigators found.

"If you extrapolate these findings to the U.S., if you treat all patients with bacterial meningitis with dexamethasone, that would save one life every day," van de Beek said.

Guidelines in the United States recommend the use of dexamethasone for suspected cases of bacterial meningitis, he added.

Jeffrey Cirillo, an associate professor of microbial and molecular pathogenesis at Texas A&M Health Science Center College of Medicine, said that the study's results confirmed previous findings in clinical trials and laboratory models that dexamethasone treatment in combination with antibiotics can reduce mortality in patients.

"These results strongly support the use of dexamethasone in cases of pneumococcal meningitis and offer promise to improve the chances of survival from meningitis, a frequently deadly illness," Cirillo added.

Since 2000, a vaccine against bacterial meningitis has been available. A study last year confirmed that the vaccine has significantly cut the number of cases of the disease.

Overall, the number of cases of the disease dropped 30 percent in that time, but the effect on the very youngest and oldest was even more pronounced: Incidence decreased by 64 percent in those younger than 2 and by 54 percent in those older than 65, according to the report, published in the Jan. 15, 2009 issue of the New England Journal of Medicine.

The vaccine, known as Prevnar and made by Wyeth Pharmaceuticals, is part of the standard vaccination recommendation for children in the United States ages 2 to 23 months, as well as for children 24 to 59 months old who are at high risk for pneumococcal disease.

Meningitis causes inflammation to the membranes in the brain and spinal cord. Bacterial meningitis, unlike viral meningitis, can be deadly and can also cause hearing loss, brain damage and learning disabilities. The most common and severe form of bacterial meningitis is pneumococcal meningitis. About 30 percent of people with bacterial meningitis die from it, according to background information provided in a news release from the American Academy of Neurology.

More information

For more information on bacterial meningitis, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: Diederik van de Beek, M.D., Ph.D., clinical neurologist, Academic Medical Center, University of Amsterdam, the Netherlands; Jeffrey Cirillo, Ph.D., associate professor, microbial and molecular pathogenesis, Texas A&M Health Science Center College of Medicine, College Station, Texas; Sept. 29, 2010, Neurology, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Prozac and Celexa exhibit anti-inflammatory effects
2. Physician's Pain Relief Cream Includes Patented Anti-inflammatory in New Formula
3. Two New Phytochemicals with Anti-Inflammatory Activity Found in Noni Fruit
4. New research reinforces anti-inflammatory properties of tart cherries
5. Grant for rotten eggs anti-inflammatory research
6. UNT Health Science Centers Roby Helps Identify Bodies of Chiles Patio 29
7. MarquisNet Co-Location Agreement with MessageBroadcast Helps Message Delivery Provider Expand World-Class Network
8. Launch of On Time Air Filters: Home Air Filter Delivery Service Helps Homeowners Replace All-Important Home HVAC Filters On Time
9. New intervention helps Latino parents of asthmatic children quit smoking
10. Hair Loss: Must See Photos - Scalpure Hair Mask Helps Hair Loss
11. Exercise helps protect brain of multiple sclerosis patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Anti-Inflammatory Helps Treat Bacterial Meningitis: Study
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... California (PRWEB) , ... May 26, 2016 , ... ... associated with discovery of thousands of defective respirators, according to court documents and ... the case of William and Becky Tyler v. American Optical Corporation, Case No. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through ... a partner for the Tamika Catchings Legacy Tour that will commemorate the ... in hardwood basketball surfaces in all forms and levels of the game, Connor Sports ...
(Date:5/26/2016)... PA (PRWEB) , ... May 26, 2016 , ... ... and one that has a significant negative impact on long-term patient survival, reports ... date. The results, published online this week in the Journal of Thoracic and ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Israel , May 27, 2016 ... an innovative biopharmaceutical company focused on late-stage drug ... Dexcel Pharma of pivotal batches required ... and Drug Administration (FDA). This follows Kitov,s ... Phase III trial successfully met its primary efficacy ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
Breaking Medicine Technology: